Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. - Wikidata - wikimedia - TriplyDB

Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.

Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.

http://www.wikidata.org/entity/Q34144695

about

Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance Extraneural Glioblastoma Multiforme Vertebral Metastasis Non-invasive metabolic imaging of brain tumours in the era of precision medicine.Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.NKG2D Receptor and Its Ligands in Host Defense Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.Mechanism of immune evasion in breast cancer.Therapeutic potential and challenges of natural killer cells in treatment of solid tumors The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor.Sexual dimorphism in glioma glycolysis underlies sex differences in survival MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment.Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma.ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.Developing immunotherapeutic strategies to target brain tumors.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.Prognostic significance of serum lactate dehydrogenase levels in Ewing's sarcoma: A meta-analysis.NKG2D ligand expression in pediatric brain tumors.Mechanisms regulating immune surveillance of cellular stress in cancer.Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice.IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy.Current state and future prospects of immunotherapy for glioma.Immunomethylomics: A Novel Cancer Risk Prediction Tool.Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments.Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages.The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.A previously unidentified mechanism of immune evasion in glioblastoma.Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1ε with NK Cells Impacts NKG2D Expression and Function The Paradoxical Role of NKG2D in Cancer Immunity

P2860

Q26766711-C3170F70-FB6C-4AFC-AE14-607B77939740 Q26771976-B26D6356-F71C-48A3-81E1-6F9679A8A992 Q31115540-929CD45F-20E8-4C3B-BB37-572F7A34649B Q35541252-3704804B-123D-4382-8699-B198B409B7DE Q35687826-A8805950-C848-40F7-BBFE-FA18932D9012 Q35962134-F1754CF5-079B-4C9C-A30C-14695EE861F9 Q36192530-CC688A27-3DA6-4834-A382-46B9A28C4475 Q36868340-0CBF1C90-F810-4CAD-A493-047DC973C10F Q37079098-7E094010-6530-4113-B464-5BC413A9D5EB Q37622429-B6EF52A8-82F6-49B3-9CB8-AEC5CC76C8E2 Q37712385-4DFE83F8-C8D3-4DDE-8F07-C9CA00D609D7 Q38478878-406B453A-621E-4C78-912E-F132998ACFEE Q38565718-E19DDEC2-4211-4ACA-AABD-90EA72BB1A8C Q38645948-AFD6FEA7-F835-404B-AFD4-DB102BF9FB88 Q38671546-22ADEC00-24F0-4763-B378-690B0CF1AFEC Q38800732-230572AE-68BE-4F3C-AFE3-D1A43DCC97A4 Q38809719-C7E16162-98BC-4198-96C6-44D8547DC96E Q38814097-08B26290-F8E5-4F77-9EB4-49E68EE2E358 Q38851464-827F2EE2-491D-4059-BAEC-654AB93FDFA3 Q38958563-93137BEC-3101-43EF-8ECF-944F7F2A58FB Q39095969-44FE8638-CC0A-45CC-8CAB-42AEFBB33348 Q39196323-ABEFD7DB-2DBA-4C54-8ED7-78BE3E417B81 Q39458697-047BE583-5423-4852-95B3-D3BF93E9CE7C Q40115962-2CE07199-AFF9-40A8-B3D1-1E794D3A04E0 Q40301456-F618B647-8973-47F7-961F-1B271206CFC0 Q41654263-BDE2386F-891E-4605-9977-5C9EFBDEF586 Q43103834-B4E2276D-994E-4A31-891D-EA0A75C9E70C Q50109459-6D22F58E-5EB3-4ECF-BB6F-6045C6E7C224 Q52574828-482E330A-D981-456B-9FB1-3C85FB67FD50 Q52599425-244E763D-D9DF-4BA7-BA22-E6042AB52659 Q52780147-5BB074DD-EB62-4F78-B8CC-F8E3BBCEACB5 Q53453272-8C68531E-1663-4443-8656-6ADC6CCCD69D Q53737755-80FC34C1-5A59-4E37-A420-E02C23846978 Q54979162-1F4E52E3-B2E5-4124-BA9B-82729788B134 Q55001650-B16E37F2-763D-4E6B-9E52-3E667017F9DF Q55234629-1329ED17-40FD-4341-A2B9-CC69C1881F2C Q55460347-80E8B4B7-3B9D-428F-B77A-611D9F4230D2 Q58129521-1250C751-B761-4857-952C-41DC259124C4 Q58620998-81F9686C-422A-466F-B30E-C62218FCFDD6 Q58785685-604F33D6-6DA6-4C46-9351-777C16E7E30C

P2860

Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.

http://www.wikidata.org/entity/Q34144695

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@ast

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@en

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@nl

type

label

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@ast

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@en

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@nl

prefLabel

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@ast

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@en

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@nl

P1433

Q34144695-D696AB1E-4290-4658-ABCF-4E633B834018

P1476

Q34144695-5CB724A8-10DB-41EA-99C1-BC4CC7CD3165

P2093

Q34144695-02FE49B7-C8DC-4400-8718-8C0A329A2B45

Q34144695-0FA7957B-F393-4091-8628-2A689ED50FD9

Q34144695-1D0CD69D-1054-43B7-9F18-0FD2EF6DDEFE

Q34144695-2F7609A8-DDD2-4A4E-A503-3EB87AC6D8EE

Q34144695-508CA194-6817-4525-864C-1D996180F435

Q34144695-5D8C48EE-A260-4420-91AD-5F7BE1FF4817

Q34144695-9AD8070D-7256-4BBB-A4C5-71495620BAA1

Q34144695-BB62010B-098B-4375-B333-22156365C30C

Q34144695-CEC1C774-2C5B-4597-939E-10920422C960

Q34144695-DC01DE74-B7AB-44BD-8915-75280028841C

P2860

Q34144695-1233E800-F83D-4FBA-86C4-56557B5CE15F

Q34144695-1FBF709F-9092-42E4-9F89-2577F57E220F

Q34144695-308BF208-9003-4718-BD12-959809A0369B

Q34144695-3703944B-7B44-44A3-B0EF-AB759158AAB7

Q34144695-48677B46-6F23-404E-9F3F-3D9ADE89070B

Q34144695-4EFE5F84-E3EB-42B8-A8CF-19F1EB5EFACF

Q34144695-57116824-54A9-4C3A-B70A-D8C7AF20557F

Q34144695-82B72D3F-6989-472A-890A-7F6E4B805B61

Q34144695-8E6A1099-6F83-4397-954D-27BBFA042CFD

Q34144695-8E9B3E0B-8EFC-402F-BF34-A53B8EBF77F2

P304

Q34144695-9B2B5EB6-7681-4DC0-A11A-A447484DB4D5

P31

Q34144695-B0891B76-0511-450F-8BDC-7F60C7067E78

P356

Q34144695-C5FB8D39-71AC-44F6-BFFC-48007D36912F

P407

Q34144695-68A466BB-F57D-45EF-8CF1-D234CC1565DA

P433

Q34144695-D3FD16D4-9EE6-49EA-A0C2-FFADC430E157

P478

Q34144695-EFF1C1CA-EF4A-4C1F-B312-B997AD44D547

P577

Q34144695-6D74791B-1B9B-414A-9262-566864DD2476

P5875

Q34144695-FEC6C334-434A-48AC-A2D6-B8836B9E75F2

P698

Q34144695-219450ED-CAA7-4938-9FEC-DE9BB508EE72

P932

Q34144695-A9B98F66-26E1-4E58-8BB3-0FE2A6072D15

P356

PNAS.1413933111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immune evasion mediated by tum ...... ells in glioblastoma patients.

@en

P2093

Andrew T Parsa

http://www.w3.org/2001/XMLSchema#string

Carly Hofmann

http://www.w3.org/2001/XMLSchema#string

Courtney A Crane

http://www.w3.org/2001/XMLSchema#string

Kara White Moyes

http://www.w3.org/2001/XMLSchema#string

Kathryn Austgen

http://www.w3.org/2001/XMLSchema#string

Kristen Haberthur

http://www.w3.org/2001/XMLSchema#string

Lawrence Fong

http://www.w3.org/2001/XMLSchema#string

Lewis L Lanier

http://www.w3.org/2001/XMLSchema#string

Lia Avanesyan

http://www.w3.org/2001/XMLSchema#string

Michael J Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Immunosuppressive strategies that are mediated by tumor cells

Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance.

Immunosurveillance of senescent cancer cells by natural killer cells

Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1

Regulation of ligands for the NKG2D activating receptor.

Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D.

P304

12823-12828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1413933111

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264903304

http://www.w3.org/2001/XMLSchema#string

P698

25136121

http://www.w3.org/2001/XMLSchema#string

P932

4156766

http://www.w3.org/2001/XMLSchema#string